marimastat has been researched along with bb 2116 in 2 studies
| Studies (marimastat) | Trials (marimastat) | Recent Studies (post-2010) (marimastat) | Studies (bb 2116) | Trials (bb 2116) | Recent Studies (post-2010) (bb 2116) |
|---|---|---|---|---|---|
| 215 | 28 | 53 | 10 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hooper, NM; Hussain, I; Karran, EH; Parvathy, S; Turner, AJ | 1 |
| Hooper, NM; Parkin, ET; Trew, AJ; Turner, AJ | 1 |
1 review(s) available for marimastat and bb 2116
| Article | Year |
|---|---|
The role of proteolysis in Alzheimer's disease.
Topics: ADAM Proteins; ADAM17 Protein; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Biotinylation; Endopeptidases; Humans; Hydroxamic Acids; Membrane Lipids; Membrane Proteins; Metalloendopeptidases; Nerve Tissue Proteins; Phenylalanine; Presenilin-1; Presenilin-2; Protease Inhibitors; Rats; Thiophenes | 2000 |
1 other study(ies) available for marimastat and bb 2116
| Article | Year |
|---|---|
The amyloid precursor protein (APP) and the angiotensin converting enzyme (ACE) secretase are inhibited by hydroxamic acid-based inhibitors.
Topics: Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Cell Line; Cells, Cultured; Endopeptidases; Endothelium, Vascular; Humans; Hydroxamic Acids; Peptidyl-Dipeptidase A; Phenylalanine; Protease Inhibitors; Protein Processing, Post-Translational; Thiophenes; Umbilical Veins | 1998 |